First of all I am quite positive the post was not addressed
First of all I am quite positive the post was not addressed to you, so I certainly did not tell you how you should feel.
That is crystal clear. You self assigned a comment to another upon yourself .
Second, I believe this is an investors forum, not only a forum to adulate and kiss John Bordynuiks ass for dragging out for years the goals and expectations he said were coming and thereby diminishing any value to stockholders.
He has published and verified comments as to progress over the years that have never been met. I consider that inexcusable as a shareholder who has seen an erosion of share value directly because of it.
32 friggin cents and consistantly down for years.
That's reality.
Everything else is just noise.
This is the stock market, not the invest and dream market as millions of dollars and 5 years go by.
The ONLY object of the stock market is to see profits, and that is clearly not happening because of JB's failure to achieve his stated goals.
I have every right to be pissed and voice my complaints. This company is not showing returns and that is what this is all about. Not 'just keep waiting and I will give it all the time it needs". 5 years , let that sink in.
And it does not matter if you are one of the early investors. Every investor is the same no matter when they bought.
And why are you assigning the term 'detractor' to anyone who has issues with the way this company is performing ?
It clearly has consistently underachieved and over promised and I prefer to call a spade a spade, not sugar coat reality.
The share price is in the toilet after 5 years of waiting.
Calling shareholders who question anything not in a positive light 'detractors' is putting us on a level with the people who say this is a scam.
And that is just wrong and you know it.
So according to you, if a shareholder even questions why they have taken continuous losses over the years they become 'detractors'.
Ridiculous.
Go to any AGM of any legit public company that shows shareholder losses for 4-5 years, the board and management are held accountable by shareholders. Why, according to you, is shareholder of JBI who voices the same kind of complaint , after 4-5 years of waiting, a 'detractor' ?
JB has accountability, not a free pass from idol worshippers, which not all of us are anymore.
When a company and it's operations are not performing and it shows in my account continually I prefer to tell the truth.
JB is not getting it done. Plain and simple.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...
Continue Reading
The Big Move in Correctional Healthcare VitalCore Health Strategies has made an impressive move with the opening of a 60-bed Behavioral Health Unit at Shawnee County Jail in Topeka, Kansas. The unit, part of a $21 million expansion completed on August 24, is set to change the landscape for inmates needing mental health and substance use treatment. This isn't just a slap...
Continue Reading
Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...
Continue Reading
Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...
Continue Reading
When Two AI Giants Collide Every so often, we get a clash of titans in the business world, and this time it's in the AI universe. New York's Moonshot AI, a champ in autonomous website optimization, hit a bump when its name collided with a Chinese counterpart, also called Moonshot AI. And just like that, the NY company had to chuck their name out the window and don a new...
Continue Reading
Pest Trouble Brewing in Mandeville: A Health Alert There’s a storm brewing in Mandeville, Louisiana, and it's not the kind you can see rolling in on the horizon. We're talking about those sneaky pests going unnoticed in our homes. Folks, these pests aren't just a nuisance; they're ticking time bombs for public health. Take it from J&J Exterminating, who know a thing or...
Continue Reading
Shaking Up the Window Screens Biz If you've been grinding in the window and door game, you know it's not an industry with a lot of buzz, but here comes a shot of caffeine. FlexScreen and RiteScreen just snagged David Whisenhunt to rev up their sales machine. Who's David Whisenhunt? Well, he's no rookie. With over two decades deep in the fenestration field, Whisenhunt...
Continue Reading
A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...
Continue Reading
Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...
Continue Reading
Seems like Hanover Foods is turning heads with their move into the ever-demanding health-conscious market. This family's stepping into the limelight with their new Skinny Veg® line, clearly targeting folks riding the GLP-1 wave. You see, it's not every day that a company that's been around the block since 1924 shakes things up like this. Simplicity is the Name of the...
Continue Reading
Top 5 Most Recently Viewed Articles
Nextchip Teams Up with Arteris for Enhanced Automotive Vision Nextchip, a forerunner in automotive semiconductor designs, has recently engaged Arteris, Inc., known for its expertise in system IP, to bolster its development of advanced vision technology in vehicles. Utilizing Arteris' renowned FlexNoC network-on-chip (NoC) interconnect IP equipped with Functional Safety...
Continue Reading
Key Q3 2025 Highlights Conduent Incorporated (NASDAQ: CNDT), a leading global technology-driven business process solutions provider, recently shared its financial results for the third quarter of 2025. This quarter saw the successful completion of significant milestones that forecast not only growth but also innovative operational strategies. Financial Overview Total...
Continue Reading
Pennant Group's Financial Highlights for Fiscal Year 2024 In a compelling display of resilience and growth, The Pennant Group, Inc. (NASDAQ: PNTG) has unveiled its financial performance for the fiscal year 2024, showcasing remarkable achievements across various operational segments. The company reported GAAP diluted earnings per share of $0.70 for the entire fiscal year...
Continue Reading
NTG Nordic Transport Group's Interim Report for H1 2025 NTG Nordic Transport Group has successfully released its interim report for the first half of 2025. This report provides essential insights into the company's performance during this period and outlines future strategies. Financial Performance Overview In this interim report, NTG presents a comprehensive analysis of...
Continue Reading
Employee Stock Options and RSU Grants by Cytokinetics Cytokinetics, Incorporated (Nasdaq: CYTK) recently made headlines by granting stock options and restricted stock units (RSUs) to new employees. This strategic move took place in mid-October 2025, marking a significant step in the company’s effort to attract and retain talent within the biopharmaceutical industry....
Continue Reading